Business Context and Reporting Period
This Form 8-K Current Report was filed by NewAmsterdam Pharma Company N.V. on June 11, 2025. The filing serves as a Regulation FD disclosure regarding an upcoming Research & Development Day event scheduled for the same date.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural disclosure and does not contain financial statements or performance metrics.
Material Changes
No material changes to financial position or operations are reported in this document. The filing solely announces the scheduling of an investor event.
Guidance, Outlook, and Management Commentary
- Event Announcement: The Company will host a Research & Development Day for analysts and investors on June 11, 2025, at 9 a.m. ET in New York City.
- Access: A live webcast is available via the investor relations website, with an archived replay accessible for 30 days.
- Legal Status: The information, including the presentation furnished as Exhibit 99.1, is "furnished" and not "filed" under the Exchange Act. It is not subject to liability under Section 18 of the Exchange Act or Sections 11 and 12(a)(2) of the Securities Act.
- Incorporation by Reference: This information shall not be incorporated by reference into any registration statement or other document unless expressly stated.
Key Facts for Investor Verification
- Verify the date and time of the Research & Development Day (June 11, 2025, 9 a.m. ET).
- Confirm the availability of the live webcast and archived replay on the Company's investor relations website.
- Note that the presentation materials are furnished as Exhibit 99.1 and are not legally "filed" for liability purposes.
- Recognize that this filing contains no financial data or updated guidance figures.